Lite Strategy reports first fiscal year under Litecoin treasury strategy
Lite Strategy (NASDAQ:LITS) reported fiscal 2026 results for the year ended June 30, marking its first fiscal year operating under a Litecoin treasury strategy.
Lite Strategy (NASDAQ:LITS) reported fiscal 2026 results for the year ended June 30, marking its first fiscal year operating under a Litecoin treasury strategy.
1-800-FLOWERS.COM (NASDAQ:FLWS) announced a definitive agreement to sell PersonalizationMall.com and Things Remembered to PlanetArt, LLC for approximately $45 million in cash.
Iovance Biotherapeutics (NASDAQ:IOVA) raised its full-year 2026 revenue guidance following stronger-than-expected demand for its commercial products, Amtagvi and Proleukin.
Nurix Therapeutics (NASDAQ:NRIX) announced that it achieved a $7 million research milestone under its collaboration with Pfizer (NYSE:PFE) to develop degrader antibody conjugates.
BeyondSpring (NASDAQ:BYSI) announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to Plinabulin in combination with docetaxel for previously treated advanced non-squamous lung cancer.
BIO-key (NASDAQ:BKYI) announced a partnership with Al Majlis Group to introduce its identity security platform to organizations in the United Arab Emirates and Saudi Arabia.
Immix Biopharma (NASDAQ:IMMX) reported interim results from its Phase 2 NEXICART-2 clinical trial evaluating NXC-201 in patients with relapsed or refractory AL amyloidosis.
Turbo Energy (NASDAQ:TURB) reported first-half 2026 financial results, with significant revenue growth and a return to profitability.
Johnson & Johnson (NYSE:JNJ) reported two-year findings for IMAAVY in adolescents with generalized myasthenia gravis (gMG), along with results from a retrospective survey evaluating adults who switched to the therapy from other advanced treatments.
Caterpillar (NYSE:CAT) announced an agreement to acquire John Fabick Tractor Company, an independent Cat dealer serving customers across parts of the Midwest United States.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy